FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kathryn Carlson

Research Profile

Chemicals & Drugs

Living Beings

Rats

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jian Min; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Pengcheng Wang; Kathryn E Carlson; Pu Guo; Minjian Huang; John A Katzenellenbogen; Hai-Bing Zhou
Thiophene-core estrogen receptor ligands having superagonist activity.
Manghong Zhu; Kathryn E Carlson; Valerie Cavett; Chune Dong; John A Katzenellenbogen; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Chen Zhang; Yangfan Zheng; Hai-Bing Zhou
Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.
Yangfan Zheng; Manghong Zhu; Kathryn E Carlson; Valerie Cavett; Chune Dong; John A Katzenellenbogen; Jian Min; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Pengcheng Wang; Hai-Bing Zhou
Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligands.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kathryn Carlson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jian Min; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Pengcheng Wang; Kathryn E Carlson; Pu Guo; Minjian Huang; John A Katzenellenbogen; Hai-Bing Zhou
Thiophene-core estrogen receptor ligands having superagonist activity.
Journal of medicinal chemistry 2013;56(8):3346-66.
2012: Manghong Zhu; Kathryn E Carlson; Valerie Cavett; Chune Dong; John A Katzenellenbogen; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Chen Zhang; Yangfan Zheng; Hai-Bing Zhou
Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides.
Organic & biomolecular chemistry 2012;10(43):8692-700.
2012: Yangfan Zheng; Manghong Zhu; Kathryn E Carlson; Valerie Cavett; Chune Dong; John A Katzenellenbogen; Jian Min; Kendall W. Nettles; Jerome C Nwachukwu; Sathish Srinivasan; Pengcheng Wang; Hai-Bing Zhou
Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligands.
ChemMedChem 2012;7(6):1094-100.
2012: Pengcheng Wang; Yangfan Zheng; Manghong Zhu; Kathryn E Carlson; Valerie Cavett; Chune Dong; Pu Guo; John A Katzenellenbogen; Jian Min; Kendall W. Nettles; Jerome C Nwachukwu; Hai-Bing Zhou
Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.
Journal of medicinal chemistry 2012;55(5):2324-41.
2011: Simone Bertini; Andrea De Cupertinis; Carlotta Granchi; Barbara Bargagli; Tiziano Tuccinardi; Adriano Martinelli; Marco Macchia; Jillian Rebecca Gunther; Kathryn E Carlson; John A Katzenellenbogen; Filippo Minutolo
Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.
European journal of medicinal chemistry 2011;46(6):2453-62.
2011: M Jeyakumar; Kathryn E Carlson; Jillian R Gunther; John A Katzenellenbogen
Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities.
The Journal of biological chemistry 2011;286(15):12971-82.
2010: Jae Hak Lee; Hai-Bing Zhou; Carmen S Dence; Kathryn E Carlson; Michael J Welch; John A Katzenellenbogen
Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Bioconjugate chemistry 2010;21(6):1096-104.
2010: Hai-Bing Zhou; Jae Hak Lee; Christopher G Mayne; Kathryn E Carlson; John A Katzenellenbogen
Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.
Journal of medicinal chemistry 2010;53(8):3349-60.
2010: Karen J Kieser; Dong Wook Kim; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Characterization of the pharmacophore properties of novel selective estrogen receptor downregulators (SERDs).
Journal of medicinal chemistry 2010;53(8):3320-9.
2009: Michael Waibel; Karen J Kieser; Kathryn E Carlson; Fabio Stossi; Benita S Katzenellenbogen; John A Katzenellenbogen
Phenethyl pyridines with non-polar internal substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3560-70.
2009: Michael Waibel; Meri De Angelis; Fabio Stossi; Karen J Kieser; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta.
European journal of medicinal chemistry 2009;44(9):3412-24.
2009: Andrew L LaFrate; Kathryn E Carlson; John A Katzenellenbogen
Steroidal bivalent ligands for the estrogen receptor: design, synthesis, characterization and binding affinities.
Bioorganic & medicinal chemistry 2009;17(10):3528-35.
2009: Filippo Minutolo; Simone Bertini; Carlotta Granchi; Teresa Marchitiello; Giovanni Prota; Simona Rapposelli; Tiziano Tuccinardi; Adriano Martinelli; Jillian Rebecca Gunther; Kathryn E Carlson; John A Katzenellenbogen; Marco Macchia
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Journal of medicinal chemistry 2009;52(3):858-67.
2009: Hai-Bing Zhou; Kathryn E Carlson; Fabio Stossi; Benita S Katzenellenbogen; John A Katzenellenbogen
Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor alpha selective activity.
Bioorganic & medicinal chemistry letters 2009;19(1):108-10.
2008: Andrew L LaFrate; Jillian Rebecca Gunther; Kathryn E Carlson; John A Katzenellenbogen
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
Bioorganic & medicinal chemistry 2008;16(23):10075-84.
2008: Filippo Minutolo; R Bellini; Simone Bertini; Isabella Carboni; Annalina Lapucci; Letizia Pistolesi; Giovanni Prota; Simona Rapposelli; Francesca Solati; Tiziano Tuccinardi; Adriano Martinelli; Fabio Stossi; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen; Marco Macchia
Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
Journal of medicinal chemistry 2008;51(5):1344-51.
2007: Ephraim E Parent; Kathryn E Carlson; John A Katzenellenbogen
Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography.
The Journal of organic chemistry 2007;72(15):5546-54.
2007: Hai-Bing Zhou; Kendall W. Nettles; John B Bruning; Younchang Kim; Andrzej Joachimiak; Sanjay Sharma; Kathryn E Carlson; Fabio Stossi; Benita S Katzenellenbogen; Geoffrey L Greene; John A Katzenellenbogen
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands.
Chemistry & biology 2007;14(6):659-69.
2007: Hai-Bing Zhou; Shubin Sheng; Dennis R Compton; Younchang Kim; Andrzej Joachimiak; Sanjay Sharma; Kathryn E Carlson; Benita S Katzenellenbogen; Kendall W. Nettles; Geoffrey L Greene; John A Katzenellenbogen
Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains.
Journal of medicinal chemistry 2007;50(2):399-403.
2005: Anobel Tamrazi; Kathryn E Carlson; Alice L Rodriguez; John A Katzenellenbogen
Coactivator proteins as determinants of estrogen receptor structure and function: spectroscopic evidence for a novel coactivator-stabilized receptor conformation.
Molecular endocrinology (Baltimore, Md.) 2005;19(6):1516-28.
2005: Sung Hoon Kim; Anobel Tamrazi; Kathryn E Carlson; John A Katzenellenbogen
A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality.
Molecular & cellular proteomics : MCP 2005;4(3):267-77.
2004: Dennis R Compton; Shubin Sheng; Kathryn E Carlson; Natalie A Rebacz; In Young Lee; Benita S Katzenellenbogen; John A Katzenellenbogen
Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
Journal of medicinal chemistry 2004;47(24):5872-93.
2004: Dennis R Compton; Kathryn E Carlson; John A Katzenellenbogen
Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core.
Bioorganic & medicinal chemistry letters 2004;14(22):5681-4.
2004: Sung Hoon Kim; Anobel Tamrazi; Kathryn E Carlson; Jonathan R Daniels; In Young Lee; John A Katzenellenbogen
Estrogen receptor microarrays: subtype-selective ligand binding.
Journal of the American Chemical Society 2004;126(15):4754-5.
2004: Kyle M Hurth; Mark Joseph Nilges; Kathryn E Carlson; Anobel Tamrazi; R Linn Belford; John A Katzenellenbogen
Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
Biochemistry 2004;43(7):1891-907.
2003: Rajeev S Muthyala; Kathryn E Carlson; John A Katzenellenbogen
Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor.
Bioorganic & medicinal chemistry letters 2003;13(24):4485-8.
2003: Anobel Tamrazi; Kathryn E Carlson; John A Katzenellenbogen
Molecular sensors of estrogen receptor conformations and dynamics.
Molecular endocrinology (Baltimore, Md.) 2003;17(12):2593-602.
2003: Rajeev S Muthyala; Shubin Sheng; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor.
Journal of medicinal chemistry 2003;46(9):1589-602.
2003: Usha Ghosh; Deshanie Ganessunker; Viswajanani J Sattigeri; Kathryn E Carlson; Deborah J Mortensen; Benita S Katzenellenbogen; John A Katzenellenbogen
Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
Bioorganic & medicinal chemistry 2003;11(4):629-57.
2002: Anobel Tamrazi; Kathryn E Carlson; Jonathan R Daniels; Kyle M Hurth; John A Katzenellenbogen
Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate.
Molecular endocrinology (Baltimore, Md.) 2002;16(12):2706-19.
2001: Marvin J Meyers; Jun Sun; Kathryn E Carlson; G A Marriner; Benita S Katzenellenbogen; John A Katzenellenbogen
Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
Journal of medicinal chemistry 2001;44(24):4230-51.
2001: DS Mortensen; Alice L Rodriguez; Kathryn E Carlson; Jun Sun; Benita S Katzenellenbogen; John A Katzenellenbogen
Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
Journal of medicinal chemistry 2001;44(23):3838-48.
1999: Arvin Gee; Kathryn E Carlson; P G Martini; Benita S Katzenellenbogen; John A Katzenellenbogen
Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Molecular endocrinology (Baltimore, Md.) 1999;13(11):1912-23.
1999: Marvin J Meyers; Jun Sun; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Journal of medicinal chemistry 1999;42(13):2456-68.
1998: Marvin J Meyers; Kathryn E Carlson; John A Katzenellenbogen
Facile synthesis of high affinity styrylpyridine systems as inherently fluorescent ligands for the estrogen receptor.
Bioorganic & medicinal chemistry letters 1998;8(24):3589-94.
1997: Kathryn E Carlson; I Choi; Arvin Gee; Benita S Katzenellenbogen; John A Katzenellenbogen
Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Biochemistry 1997;36(48):14897-905.
1995: D A Seielstad; Kathryn E Carlson; P J Kushner; G L Greene; John A Katzenellenbogen
Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis.
Biochemistry 1995;34(39):12605-15.
1995: D A Seielstad; Kathryn E Carlson; John A Katzenellenbogen; P J Kushner; G L Greene
Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli.
Molecular endocrinology (Baltimore, Md.) 1995;9(6):647-58.
1995: R J Miksicek; Kathryn E Carlson; K J Hwang; John A Katzenellenbogen
Studies using fluorescent tetrahydrochrysene estrogens for in situ visualization of the estrogen receptor in living cells.
Molecular endocrinology (Baltimore, Md.) 1995;9(5):592-604.
1995: P R Kym; Kathryn E Carlson; John A Katzenellenbogen
Evaluation of a highly efficient aryl azide photoaffinity labeling reagent for the progesterone receptor.
Bioconjugate chemistry 1995;6(1):115-22.
1994: K E Bergmann; C H Wooge; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Bivalent ligands as probes of estrogen receptor action.
The Journal of steroid biochemistry and molecular biology 1994;49(2-3):139-52.
1994: James P O'Neil; Kathryn E Carlson; Carolyn J Anderson; Michael J Welch; John A Katzenellenbogen
Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
Bioconjugate chemistry 1994;5(3):182-93.
1994: K E Bergmann; Kathryn E Carlson; John A Katzenellenbogen
Hexestrol diazirine photoaffinity labeling reagent for the estrogen receptor.
Bioconjugate chemistry 1994;5(2):141-50.
1994: K E Bergmann; S W Landvatter; P G Rocque; Kathryn E Carlson; Michael J Welch; John A Katzenellenbogen
Oxohexestrol derivatives labeled with fluorine-18. Synthesis, receptor binding and in vivo distribution of two non-steroidal estrogens as potential breast tumor imaging agents.
Nuclear medicine and biology 1994;21(1):25-39.
1993: Gregory M Anstead; Kathryn E Carlson; P R Kym; K J Hwang; John A Katzenellenbogen
The effect of acceptor group variation on the solvatochromism of donor-acceptor fluorophores.
Photochemistry and photobiology 1993;58(6):785-94.
1993: Henry VanBrocklin; Kathryn E Carlson; John A Katzenellenbogen; Michael J Welch
16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
Journal of medicinal chemistry 1993;36(11):1619-29.
1993: M J Kochanny; Henry VanBrocklin; P R Kym; Kathryn E Carlson; James P O'Neil; T A Bonasera; Michael J Welch; John A Katzenellenbogen
Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.
Journal of medicinal chemistry 1993;36(9):1120-7.
1993: P R Kym; Kathryn E Carlson; John A Katzenellenbogen
Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation.
Journal of medicinal chemistry 1993;36(9):1111-9.
1993: Henry VanBrocklin; P A Rocque; H V Lee; Kathryn E Carlson; John A Katzenellenbogen; Michael J Welch
16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors.
Life sciences 1993;53(10):811-9.
1992: K J Hwang; Kathryn E Carlson; Gregory M Anstead; John A Katzenellenbogen
Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of receptor.
Biochemistry 1992;31(46):11536-45.
1992: A Liu; Kathryn E Carlson; John A Katzenellenbogen
Synthesis of high affinity fluorine-substituted ligands for the androgen receptor. Potential agents for imaging prostatic cancer by positron emission tomography.
Journal of medicinal chemistry 1992;35(11):2113-29.
1992: J P DiZio; Kathryn E Carlson; C J Bannochie; Michael J Welch; E Von Angerer; John A Katzenellenbogen
Estrogen platinum-diamine complexes: preparation of a non-steroidal estrogen platinum-diamine complex labeled with platinum-191 and a study of its binding to the estrogen receptor in vitro and its tissue distribution in vivo.
The Journal of steroid biochemistry and molecular biology 1992;42(3-4):363-73.
1992: Martin G Pomper; M J Kochanny; A M Thieme; Kathryn E Carlson; Henry VanBrocklin; C J Mathias; Michael J Welch; John A Katzenellenbogen
Fluorine-substituted corticosteroids: synthesis and evaluation as potential receptor-based imaging agents for positron emission tomography of the brain.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(4):461-80.
1992: K G Pinney; Kathryn E Carlson; John A Katzenellenbogen
Nonsteroidal estrogens bearing acyl azide functions: potential electrophilic and photoaffinity labeling agents for the estrogen receptor.
Steroids 1992;57(5):222-32.
1992: Henry VanBrocklin; Martin G Pomper; Kathryn E Carlson; Michael J Welch; John A Katzenellenbogen
Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(3):363-74.
1992: J P DiZio; Carolyn J Anderson; A Davison; G J Ehrhardt; Kathryn E Carlson; Michael J Welch; John A Katzenellenbogen
Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(4):558-69.
1991: K G Pinney; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Efficient and selective photoaffinity labeling of the estrogen receptor using two nonsteroidal ligands that embody aryl azide or tetrafluoroaryl azide photoreactive functions.
Biochemistry 1991;30(9):2421-31.
1990: Martin G Pomper; Henry VanBrocklin; A M Thieme; R D Thomas; D O Kiesewetter; Kathryn E Carlson; C J Mathias; Michael J Welch; John A Katzenellenbogen
11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
Journal of medicinal chemistry 1990;33(12):3143-55.
1990: Kathryn E Carlson; John A Katzenellenbogen
A comparative study of the selectivity and efficiency of target tissue uptake of five tritium-labeled androgens in the rat.
Journal of steroid biochemistry 1990;36(6):549-61.
1990: K G Pinney; Kathryn E Carlson; John A Katzenellenbogen
[3H]DU41165: a high affinity ligand and novel photoaffinity labeling reagent for the progesterone receptor.
Journal of steroid biochemistry 1990;35(2):179-89.
1990: Martin G Pomper; K G Pinney; Kathryn E Carlson; H van Brocklin; C J Mathias; Michael J Welch; John A Katzenellenbogen
Target tissue uptake selectivity of three fluorine-substituted progestins: potential imaging agents for receptor-positive breast tumors.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(3):309-19.
1989: Kathryn E Carlson; M Coppey; H Magdelenat; John A Katzenellenbogen
Receptor binding of NBD-labeled fluorescent estrogens and progestins in whole cells and cell-free preparations.
Journal of steroid biochemistry 1989;32(3):345-55.
1988: R D Bindal; Kathryn E Carlson; Benita S Katzenellenbogen; John A Katzenellenbogen
Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red.
Journal of steroid biochemistry 1988;31(3):287-93.
1988: Michael J Welch; John A Katzenellenbogen; C J Mathias; J W Brodack; Kathryn E Carlson; Dae Yoon Chi; Carmen S Dence; Michael R Kilbourn; J S Perlmutter; M E Raichle
N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(1):83-97.
1988: Kathryn E Carlson; S J Brandes; Martin G Pomper; John A Katzenellenbogen
Uptake of three [3H]progestins by target tissues in vivo: implications for the design of diagnostic imaging agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(4):403-8.
1987: R D Bindal; Kathryn E Carlson; G C Reiner; John A Katzenellenbogen
11 beta-chloromethyl-[3H]estradiol-17 beta: a very high affinity, reversible ligand for the estrogen receptor.
Journal of steroid biochemistry 1987;28(4):361-70.
1987: C J Mathias; Michael J Welch; John A Katzenellenbogen; J W Brodack; Michael R Kilbourn; Kathryn E Carlson; D O Kiesewetter
Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(1):15-25.
1986: F G Salituro; Kathryn E Carlson; J F Elliston; Benita S Katzenellenbogen; John A Katzenellenbogen
[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
Steroids 1986;48(5-6):287-313.
1983: K D McElvany; Kathryn E Carlson; John A Katzenellenbogen; Michael J Welch
Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens.
Journal of steroid biochemistry 1983;18(6):635-41.
1982: S G Senderoff; K D McElvany; Kathryn E Carlson; D F Heiman; John A Katzenellenbogen; Michael J Welch
Methodology for the synthesis and specific activity determination of 16 alpha-[77Br]-bromoestradiol-17 beta and 16 alpha-[77Br]-11 beta-methoxyestradiol-17 beta, two estrogen receptor-binding radiopharmaceuticals.
The International journal of applied radiation and isotopes 1982;33(7):545-51.
1982: K D McElvany; Kathryn E Carlson; Michael J Welch; S G Senderoff; John A Katzenellenbogen
In vivo comparison of 16 alpha[77Br]bromoestradiol-17 beta and 16 alpha-[125I]iodoestradiol-17 beta.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(5):420-4.
1982: John A Katzenellenbogen; K D McElvany; S G Senderoff; Kathryn E Carlson; S W Landvatter; Michael J Welch
16 alpha-[77Br]bromo-11 beta-methoxyestradiol-17 beta: a gamma-emitting estrogen imaging agent with high uptake and retention by target organs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1982;23(5):411-9.
1980: John A Katzenellenbogen; Kathryn E Carlson; D F Heiman; R Goswami
Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(6):550-8.